Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations (Q36721438)

15 August 2017

1 reference

title

Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations (English)

1 reference

15 August 2017

1 reference

1 reference

Martin Thornhill

18

0 references

Saman Warnakulasuriya

object named as

Saman Warnakulasuriya

19

0 references

author name string

Ibtisam Al-Hashimi

1

1 reference

15 August 2017

Mark Schifter

2

1 reference

15 August 2017

Peter B Lockhart

3

1 reference

15 August 2017

David Wray

4

1 reference

15 August 2017

Michael Brennan

5

1 reference

15 August 2017

Cesar A Migliorati

6

1 reference

15 August 2017

Tony Axéll

7

1 reference

15 August 2017

Alison J Bruce

8

1 reference

15 August 2017

William Carpenter

9

1 reference

15 August 2017

Ellen Eisenberg

10

1 reference

15 August 2017

Joel B Epstein

11

1 reference

15 August 2017

Palle Holmstrup

12

1 reference

15 August 2017

Mats Jontell

13

1 reference

15 August 2017

Francina Lozada-Nur

14

1 reference

15 August 2017

Raj Nair

15

1 reference

15 August 2017

Bud Silverman

16

1 reference

15 August 2017

Kobkan Thongprasom

17

1 reference

15 August 2017

Isaäc van der Waal

20

1 reference

15 August 2017

publication date

29 January 2007

1 reference

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

15 August 2017

published in

1 reference

15 August 2017

volume

103 Suppl

1 reference

15 August 2017

page(s)

S25.e1-12

1 reference

Lack of clinicopathologic correlation in the diagnosis of oral lichen planus based on the presently available diagnostic criteria and suggestions for modifications

15 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lichen planus: a benign lesion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Current controversies in oral lichen planus: report of an international consensus meeting. Part 1. Viral infections and etiopathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Current controversies in oral lichen planus: report of an international consensus meeting. Part 2. Clinical management and malignant transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Hepatitis C virus and lichen planus: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Number V Oral lichen planus: clinical features and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Effect of dental plaque control on gingival lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Psychosocial stressors in oral lichen planus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The evaluation of anxiety and salivary cortisol levels in patients with oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Stressful life events and skin diseases: disentangling evidence from myth.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Psychologic factors and oral lichen planus. A psychometric evaluation of 100 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

A prospective follow-up study of 570 patients with oral lichen planus: persistence, remission, and malignant association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The possible premalignant character of oral lichen planus and oral lichenoid lesions: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The clinical features, malignant potential, and systemic associations of oral lichen planus: a study of 723 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Risk of oral squamous cell carcinoma in 402 patients with oral lichen planus: a follow-up study in an Italian population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5-year experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lichen planus: patient profile, disease progression and treatment responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The role of histopathological characteristics in distinguishing amalgam-associated oral lichenoid reactions and oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Relative efficacy of fluocinolone acetonide compared with triamcinolone acetonide in treatment of oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Betamethasone valerate aerosol in the treatment of oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Fluocinonide in an adhesive base for treatment of oral lichen planus. A double-blind, placebo-controlled clinical study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Clinical evaluation in treatment of oral lichen planus with topical fluocinolone acetonide: a 2-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Topical corticosteroids in association with miconazole and chlorhexidine in the long-term management of atrophic-erosive oral lichen planus: a placebo-controlled and comparative study between clobetasol and fluocinonide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Double-blind clinical trial of 0.05% clobetasol propionate (corrected from proprionate) ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Efficacy of fluocinolone acetonide gel in the treatment of oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The treatment of oral aphthous ulceration or erosive lichen planus with topical clobetasol propionate in three preparations: a clinical and pilot study on 54 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: a randomized crossover study for the treatment of symptomatic oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Systemic and topical corticosteroid treatment of oral lichen planus: a comparative study with long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Severe oral lichen planus: treatment with an aromatic retinoid (etretinate).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Histologic changes associated with the topical use of isotretinoin on oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Efficacy of topical retinoic acid compared with topical fluocinolone acetonide in the treatment of oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lichen planus: a preliminary clinical study on treatment with tazarotene.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

A randomized trial assessing the effectiveness of different concentrations of isotretinoin in the management of lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Effect of topical cyclosporine rinse on oral lichen planus. A double-blind analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Effectiveness of a low dose of cyclosporine in the management of patients with oral erosive lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Topical cyclosporin in oral lichen planus: a controlled, randomized, prospective trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Treatment of chronic erosive oral lichen planus with low concentrations of topical tacrolimus: an open prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Management of recalcitrant ulcerative oral lichen planus with topical tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Response of oral lichen planus to topical tacrolimus in 37 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The effectiveness of 1% pimecrolimus cream in the treatment of oral erosive lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The carcinogenic potential of tacrolimus ointment beyond immune suppression: a hypothesis creating case report.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Photochemotherapy of oral lichen planus. A controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Management of oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

PUVA and cancer: a large-scale epidemiological study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Narrow-band ultraviolet B radiation: a review of the current literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft-vs.-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The clinical manifestations and treatment of oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: An open trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

A prospective study of findings and management in 214 patients with oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Prednisone and azathioprine in the treatment of patient with vesiculoerosive oral diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Mycophenolate mofetil for the treatment of acute and chronic GVHD in bone marrow transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Treatment of severe lichen planus with mycophenolate mofetil

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Amalgam-contact hypersensitivity lesions and oral lichen planus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lichen planus and allergy to dental amalgam restorations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The clinicopathological characteristics of oral lichen planus and its relationship with dental materials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lichenoid lesions related to dental restorative materials.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lichenoid reactions related to composite restorations. Preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Adverse reactions in the oral mucosa associated with anterior composite restorations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lichenoid reactions associated with amalgam: improvement after amalgam removal.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Healing of oral lichenoid lesions after replacing amalgam restorations: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Effect of replacement of dental amalgam on oral lichenoid reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lichenoid contact reactions may occasionally transform into malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral lesions and symptoms related to metals used in dental restorations: a clinical, allergological, and histologic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Amalgam-associated oral lichenoid reactions. Clinical and histologic changes after removal of amalgam fillings

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Studies of drug-induced lichenoid reactions: criteria for case selection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

7 January 2021

Graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Immunohistopathological study of the oral lichenoid lesions of chronic GVHD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Oral precancerous and malignant lesions associated with graft-versus-host disease: report of 2 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Squamous cell carcinoma of the tongue complicating chronic oral mucosal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Chronic graft versus host disease of oral mucosa: review of available therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Rapamycin (sirolimus) for treatment of chronic graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Budesonide: a novel treatment for oral chronic graft versus host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Tacrolimus ointment in the treatment of chronic cutaneous graft-vs-host disease: a case series of 18 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

CO2 laser in oral graft-versus-host disease: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Hematopoietic stem cell transplantation after reduced-intensity conditioning as treatment of sickle cell disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Erosive Lichen planus: what is this?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Scoring system for monitoring oral lichenoid lesions: a preliminary study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

[Assessment of severity of oral lichen planus using a new clinical index].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Ciclosporin vs. clobetasol in the topical management of atrophic and erosive oral lichen planus: a double-blind, randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

Extracorporeal photochemotherapy for the treatment of graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

The histopathology of oral mucosal lesions associated with amalgam or porcelain-fused-to-metal restorations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2006.11.001

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRIPLEO.2006.11.001

1 reference

15 August 2017

1 reference